Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Ordinary Shares, no par value per share
-
Shares outstanding
-
112,245,592
-
Total 13F shares
-
63,569,972
-
Share change
-
+6,151,060
-
Total reported value
-
$3,062,108,451
-
Put/Call ratio
-
23%
-
Price per share
-
$48.17
-
Number of holders
-
195
-
Value change
-
+$300,901,329
-
Number of buys
-
106
-
Number of sells
-
78
Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q1 2019
As of 31 Mar 2019,
NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by
195 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,569,972 shares.
The largest 10 holders included
FMR LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Capital World Investors, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, Darsana Capital Partners LP, STATE STREET CORP, and CREDIT SUISSE AG/.
This page lists
195
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.